The following trials provide information to treat various types of disease of the brain and the central and local nervous systems, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- collapse Open Label Extension Of Treatment With Seroquel For Patients Who Have Participated In The Phase IIIb Clinical Trial Programme
- collapse A Multi-Centre, Double-Blind, Randomised Comparison Of Seroquel And Haloperidol In The Treatment Of Subjects With Acute Exacerbation Of Subchronic And Chronic Schizophrenia.
- collapse A Multi-Centre, Double-Blind, Randomised Comparison Of Dose And Dose Regimen Of Seroquel In The Treatment Of Subjects With Acute Exacerbation Of Subchronic Or Chronic Schizophrenia.
- collapse Quetiapine in the treatment of Adolescents with schizophrenic disorders- Effiacy, Safety, and Subjective Well-Being. Pilot Study
- collapse Canada - CCT - Dr. Wolf
- collapse A open-label, comparative, multicenter, randomised, phase IV study to assess the efficacy of Seroquel and Chlorpromazine for the treatment Schizophrenia in Chinese patients for 8 weeks, Seroquel PhaseIV
- collapse Seroquel (quetiapine fumarate) Real Life Clinical Use in Schizophrenia: Non-comparative, Long Term (9-month), Open Labelo, Extension of the SECURE study.
- collapse Seroquel Clinical use in real life environment - The Secure study - A National Phase IV, Multicentre, Open-label, Non-comparative study in Schizophrenia examining the Clinical Benefit derived by patients receiving Seroquel (quetiapine fumarate)
- collapse Drug abuse patterns
- collapse Sexual dysfunction-switch study
